NTRK2 and ovarian carcinoma: BDNF/TrkB promotes ovarian cancer cell migration and invasion and it is decreased in TrkB knockdown cells while enhanced apoptosis.202 BDNF/TrkB inhibits the anoikis in human ovarian cancer cells via PI3K/AKT, generating chemoresistant cells.206